BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8001255)

  • 1. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2'-deoxyguanosine in red blood cells.
    Misra M; Alcedo JA; Wetterhahn KE
    Carcinogenesis; 1994 Dec; 15(12):2911-7. PubMed ID: 8001255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo formation of chromium(V) in chick embryo liver and red blood cells.
    Liebross RH; Wetterhahn KE
    Carcinogenesis; 1992 Nov; 13(11):2113-20. PubMed ID: 1330350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.
    Standeven AM; Wetterhahn KE
    Pharmacol Toxicol; 1991 Jun; 68(6):469-76. PubMed ID: 1891442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium (VI)-induced DNA damage in chick embryo liver and blood cells in vivo.
    Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1986 Dec; 7(12):2085-8. PubMed ID: 3779902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells.
    Sugiyama M; Tsuzuki K
    FEBS Lett; 1994 Mar; 341(2-3):273-6. PubMed ID: 8137952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI).
    Ueno S; Susa N; Furukawa Y; Sugiyama M
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):165-71. PubMed ID: 8545823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes.
    Cupo DY; Wetterhahn KE
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6755-9. PubMed ID: 3863126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione depletion enhances the formation of endogenous cyclic DNA adducts derived from t-4-hydroxy-2-nonenal in rat liver.
    Chung FL; Komninou D; Zhang L; Nath R; Pan J; Amin S; Richie J
    Chem Res Toxicol; 2005 Jan; 18(1):24-7. PubMed ID: 15651845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mutagenic DNA damage by chromium (VI) and glutathione.
    Liu S; Dixon K
    Environ Mol Mutagen; 1996; 28(2):71-9. PubMed ID: 8844987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for glutathione, independent of oxidative stress, in the developmental toxicity of methanol.
    Siu MT; Shapiro AM; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):508-15. PubMed ID: 24095963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the DNA damage threshold in breast cancer cells.
    Mobley JA; Brueggemeier RW
    Toxicol Appl Pharmacol; 2002 May; 180(3):219-26. PubMed ID: 12009861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: implications in DNA-protein crosslinking.
    Mattagajasingh SN; Misra BR; Misra HP
    J Appl Toxicol; 2008 Nov; 28(8):987-97. PubMed ID: 18615841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats.
    Bagchi D; Hassoun EA; Bagchi M; Stohs SJ
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Feb; 110(2):177-87. PubMed ID: 7599967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
    Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and DNA damage in a long-term hexavalent chromium-exposed population in North China: a cross-sectional study.
    Xu J; Zhao M; Pei L; Zhang R; Liu X; Wei L; Yang M; Xu Q
    BMJ Open; 2018 Jun; 8(6):e021470. PubMed ID: 29950470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
    Tsou TC; Lai HJ; Yang JL
    Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.